 |
인쇄하기
취소
|
GSK holds Avodart launching symposium
GlaxoSmithKline said on September 17 it held a launching symposium for Avodart (dutasteride), an oral medicine for treating symptomatic benign prostatic hyperplasia (BPH) in men.
Dr. Rosette said during the symposium, In the Netherlands, there has been growing tendency toward drug therapy in the treatment of BPH instead of surgical operations and men taking Avodart for treatment of BPH has a...
Dr. Rosette said during the symposium, In the Netherlands, there has been growing tendency toward drug therapy in the treatment of BPH instead of surgical operations and men taking Avodart for treatment of BPH has a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.